Navigation Links
AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Association for Hand Surgery 2013 Annual Meeting
Date:1/10/2013

Alachua, FL (PRWEB) January 10, 2013

AxoGen, Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today that studies based on clinical use of Avance® Nerve Graft will be presented at the 2013 Annual Meeting of the American Association for Hand Surgery, January 9-12 in Naples, FL. The two studies being presented will report on findings from the RANGER® Registry, an on-going multicenter utilization and outcomes study for Avance® Nerve Graft, a processed nerve allograft for the repair and reconstruction of peripheral nerve segmental defects.

Results from the study, “Recovery Outcomes of Short Gap Sensory Nerve Repairs with Processed Nerve Allografts from Multicenter Registry Study,” will be presented by Brian Rinker, MD, a hand surgeon from the University of Kentucky and an investigator for the RANGER® Registry, on January 11 in Naples, FL. The presentation will report on repairs for 15 subjects with 17 digital nerve injuries with gaps ranging from 5-15 mm in length.

Results from the study, “The Second Data Milestone of an Expanded Enrollment from an Ongoing Multicenter Registry Study on the Use of Processed Nerve Allograft for Sensory, Mixed, and Motor Nerve Reconstructions,” will be presented as a poster by Bauback Safa, MD of The Buncke Clinic and an investigator for the RANGER® Registry. This analysis includes outcomes from 74 repairs on sensory, motor and mixed nerves with gaps of 5 – 50 mm.

“Clinical data to support the use of Avance® Nerve Graft continues to grow,” says Erick DeVinney, Director of Clinical and Translational Science for AxoGen. “We are excited to have additional clinical data provided by experts in the field of peripheral nerve repair.”

Avance® Nerve Graft is proces
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AxoGen, Inc. to sponsor Educational Symposium and Panel Discussion at 2013 Annual Meetings of American Association for Hand Surgery, American Society for Peripheral Nerve, and American Society for Reconstructive Microsurgery
2. Sancilio and Company Announces Life Sciences Consulting Services
3. Sweet Bed Sheets Announces Launch of its New Website
4. Aventura Rejuvenation Announces Their Biggest Loser 30 Day Weight Loss Competition
5. Smile Innovations Announces New Care Credit Payment Option for Clients
6. Beautologie Announces Improvements to Their Plastic Surgery in Bakersfield,CA
7. Biophysical Society announces winners of 2013 Minority Affairs Committee travel awards
8. Karras Farm Inc. Announces that the First Baby Awassi Sheep to Be Born in the United States has Arrived
9. Hydro Med Announces the Stop Snoring Program
10. HomeCEUConnection.com Announces Launch of New Website
11. DiscountHumidifiers.com Announces New Rewards Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 TCG, a leading government technology strategy ... one of the fastest-growing companies in America for the seventh ... was previously recognized in 2013, 2012, 2011, 2010, 2009, 2008, ... grown 86% from 2010 to 2013, ranking the company at ... in America - up 635 spots from 2013! More information ...
(Date:9/2/2014)... The Wm. Jennings Bryan Dorn Veterans Affairs ... hall meeting for Veterans and their families on September 24. ... to provide Veterans with valuable healthcare and benefit information,” said ... provide a forum where we can gather important input directly ... fair will be held 4:45 p.m. to 5:45 p.m. in ...
(Date:9/2/2014)... California, the percentage undergoing a double mastectomy increased substantially ... associated with a lower risk of death than breast-conserving ... September 3 issue of JAMA . The authors ... breast was associated with a higher risk of death ... Randomized trials have demonstrated similar survival for patients with ...
(Date:9/2/2014)... September 02, 2014 Medex Analytic ... of their corporate headquarters in Coral Springs, Fla. due ... exceeded our business development objectives for the 2014 year ... Herbst. “Our industry has requested a higher level of ... reviews. Medex has delivered, and the industry has responded.” ...
(Date:9/2/2014)... 2014 (HealthDay News) -- Two new studies further confirm ... 6-year-olds who were breast-fed have a lower risk of ... while the other finds a similar trend when it ... benefits of breast-feeding in the immediate newborn period," said ... in New York City. She was not involved in ...
Breaking Medicine News(10 mins):Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... CareBETHESDA, Md., March 18 The Cystic Fibrosis Foundation ... leadership in improving the quality of care for people ... Quality Assurance (NCQA).The outlook for people with CF continues ... by the Foundation. In the 1950s, few children with ...
... 18 Medivation, Inc. (Nasdaq: MDVN ... permission from the U.S. Food and Drug Administration ... of MDV3100, its novel androgen receptor antagonist, in ... have failed docetaxel-based chemotherapy. The placebo-controlled, double-blind, ...
... inkjet printer technology, researchers say , , WEDNESDAY, March 18 ... mussels and printer inkjet technology, researchers say they,ve come ... greater precision, promote faster recovery and reduce scarring. , ... tissue together after a patient has surgery, a team ...
... protection, study finds, , , WEDNESDAY, March 18 (HealthDay News) -- ... glasses of beer or wine a day appear to have ... study suggests. , Moderate drinking has been associated with decreasing ... linked to increasing the risk for some cancers. And though ...
... Underserved by other ProvidersLOS ANGELES, March 18 ... Board: FVRL), which through its wholly-owned operating ... Personal Health Records ("PHRs") ( www.mymedicalrecords.com ) ... ( www.myesafedepositbox.com ), has entered into an ...
... March 18 Shamir Optical Industry Ltd. (Nasdaq: ... of innovative products and technology to the ophthalmic lens ... quarter and year ended December 31, 2008.For the quarter ... to $30.6 million for the fourth quarter of 2007. ...
Cached Medicine News:Health News:Cystic Fibrosis Foundation to Receive Prestigious Health Care Award 2Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 2Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 3Health News:Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer 4Health News:Mussel-Based Glue May Make Surgery Safer 2Health News:A Little Drink May Be Good for Your Bones 2Health News:A Little Drink May Be Good for Your Bones 3Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 2Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 3Health News:MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition 4Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 2Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 3Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 4Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 5Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 6Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 7Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 8Health News:Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results 9
(Date:9/2/2014)... , Sept. 2, 2014  Ameritox SM , the ... Deadly Trend: Prescription Drugs to Heroin," a research report ... heroin abuse, and examines deadly trends that have created ... here . The report is ... patients prescribed opioids. It examines five trends that distinguish ...
(Date:9/2/2014)... September 2, 2014 ... ESC-Kongress 2014 präsentierte GARFIELD-AF-Register bietet einen ... von schlaganfallgefährdeten Patienten in der klinischen ... Daten der nahezu 12.500 ... und unabhängigen Forschungsinitiative zur Untersuchung von ...
(Date:9/2/2014)... , Registry provides new insights ... and treatment satisfaction [ 1 ] ...        (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ... Barcelona, Spain : Daiichi Sankyo today ... events-European Registry in Atrial Fibrillation (PREFER in AF), revealing ...
Breaking Medicine Technology:Ameritox Research Report Reveals Pain Patients' Role in Current Heroin Epidemic 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8
... VANCOUVER, June 21, 2007 /PRNewswire-FirstCall/ - Biotech,Holdings reports ... diabetes drug its support in an overview of,diabetic ... Diabetes,Hoy, the Diabetic Federation's scientific and medical magazine ... of diabetic drugs, written by Dr. Roberto Cepeda,Gonzalez, ...
... -- Orexigen(TM),Therapeutics, Inc. , a biopharmaceutical company ... disorders with an initial focus,on obesity, today ... its lead obesity product candidate Contrave(TM) and ... fat, serum,cholesterol, and triglycerides) and insulin-resistance. The,findings ...
Cached Medicine Technology:Diabetes drug supported by Mexican Diabetes Federation 2Diabetes drug supported by Mexican Diabetes Federation 3Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 2Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 3
... with built-in bags as in a suspension file ... without contacting the ethylene glycol and without having ... ensures easy handling and maximum surface freezing concurrently ... the relatively hot air under the lid does ...
... UL Listed, CSA Certified, CE ... safely store single donor, fresh ... are standard. Cold wall refrigeration ... foamed-inplace polyurethane insulation for ultimate ...
... self-contained freezer complying with Australian Standard AS3864-1997 ... finish is grey colorbond steel with a ... to a 40-litre capacity polished stainless steel ... gasket contacting a heated top fascia. A ...
... Designed for ease of use and ... has smooth edges for comfort and is ... one-size-fits-all to a perfect fit. For hard ... a trach collar to your specifications. Don't ...
Medicine Products: